Article (Scientific journals)
Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now?
Parulski, Chloé; Jennotte, Olivier; Lechanteur, Anna et al.
2021In Advanced Drug Delivery Reviews, 175
Peer Reviewed verified by ORBi
 

Files


Full Text
Challenges of fused deposition modeling 3D printing in pharmaceutical applications - Where are we now?.pdf
Publisher postprint (2.19 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Additive manufacturing; Critical process parameters; Pharmaceutics
Abstract :
[en] In recent years, fused deposition modeling has become one of the most used threedimensional printing technologies in the pharmaceutical field. The production of personalized dosage forms for individualized therapy and the modification of the drug release profile by the elaboration of complex geometries make fused deposition modeling a promising tool for small-scale production. However, fused deposition modeling has a considerable number of challenges to overcome. They are divided into three categories of parameters. Materialspecific parameters encompass the physicochemical properties of the filament, like thermal, mechanical and rheological properties. They determine the feasibility of the printing process. Operation-specific parameters relate to the processing conditions of printing, such as printing temperature and infill density, which have an influence on the final quality and on the dissolution behavior of the objects. The printer equipment is defined by the machine-specific parameters. Some modifications of this equipment also enhance the performance of the printing process. The aim of this review is to highlight the major fused deposition modeling critical process parameters in the pharmaceutical field and possible solutions in order to speed up the development of objects in the pharmaceutical market.
Research center :
Center for Interdisciplinary Research on Medicines (CIRM)
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Parulski, Chloé  ;  Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Jennotte, Olivier ;  Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Lechanteur, Anna  ;  Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Evrard, Brigitte  ;  Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Language :
English
Title :
Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now?
Alternative titles :
[fr] Défis de l'impression 3D à modélisation par dépôt fondu dans les applications pharmaceutiques: Où en sommes-nous à présent?
Publication date :
August 2021
Journal title :
Advanced Drug Delivery Reviews
ISSN :
0169-409X
eISSN :
1872-8294
Publisher :
Elsevier, Netherlands
Special issue title :
Additive Manufacturing in Pharmaceutical Product Design
Volume :
175
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
Development of new oral formulations produced by the hot melt extrusion technique coupled with 3D printing in order to increase the solubility of active molecules like BCSII
Funders :
FEDER - Fonds Européen de Développement Régional [BE]
Available on ORBi :
since 17 June 2021

Statistics


Number of views
153 (36 by ULiège)
Number of downloads
7 (7 by ULiège)

Scopus citations®
 
71
Scopus citations®
without self-citations
67
OpenCitations
 
31

Bibliography


Similar publications



Contact ORBi